Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $7.33B | $69.53 | $139.00 | 99.91% | Strong Buy | 4 | 28.79% | 49.01% | 128.03% | 101.53% | |||
| TGTX | TG THERAPEUTICS INC | $5.04B | $31.75 | N/A | N/A | N/A | N/A | 29.44% | 78.04% | 189.41% | 74.52% | |||
| CRMD | CORMEDIX INC | $857.98M | $12.65 | $17.17 | 35.71% | Buy | 6 | 61.19% | 110.35% | 160.58% | 123.33% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.93B | $76.33 | $70.75 | -7.31% | Buy | 4 | 16.07% | 24.61% | 308.98% | 50.06% | |||
| KRYS | KRYSTAL BIOTECH INC | $4.51B | $155.71 | $195.57 | 25.60% | Strong Buy | 7 | 33.35% | 32.64% | 36.39% | 33.27% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $2.71B | $36.56 | $43.33 | 18.53% | Strong Buy | 3 | 21.07% | 229.06% | 42.44% | 31.78% | |||
| VCEL | VERICEL CORP | $1.59B | $31.42 | $58.67 | 86.72% | Strong Buy | 3 | 19.25% | 86.26% | 24.83% | 17.49% | |||
| RPRX | ROYALTY PHARMA PLC | $20.50B | $35.15 | $48.00 | 36.56% | Strong Buy | 2 | 19.54% | 48.51% | 33.32% | 17.28% | |||
| ARGX | ARGENX SE | $46.19B | $756.83 | $813.62 | 7.50% | Strong Buy | 13 | 1,383.30% | 7.11% | 35.28% | 29.97% | |||
| INVA | INNOVIVA INC | $1.23B | $19.55 | $35.33 | 80.73% | Strong Buy | 3 | 12.10% | 60.24% | 26.89% | 14.41% | |||
| EXEL | EXELIXIS INC | $10.50B | $39.01 | $46.43 | 19.02% | Buy | 14 | 10.29% | 21.56% | 69.43% | 52.72% | |||
| GYRE | GYRE THERAPEUTICS INC | $760.87M | $7.90 | $18.00 | 127.85% | Buy | 1 | 16.64% | 11.68% | 303.51% | 182.98% | |||
| ADMA | ADMA BIOLOGICS INC | $3.65B | $15.30 | $32.00 | 109.15% | Strong Buy | 1 | 18.62% | 13.60% | 100.65% | 71.80% | |||
| INCY | INCYTE CORP | $16.24B | $83.14 | $81.77 | -1.65% | Buy | 13 | 8.53% | 22.03% | 41.69% | 29.87% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.87B | $32.50 | $54.14 | 66.59% | Strong Buy | 7 | 13.74% | 15.31% | 44.58% | 31.10% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.69B | $12.81 | $13.00 | 1.48% | Buy | 2 | 13.23% | 17.95% | 20.02% | 13.36% | |||
| MDXG | MIMEDX GROUP INC | $1.03B | $6.97 | $12.00 | 72.17% | Strong Buy | 1 | 10.22% | 42.65% | N/A | N/A | |||
| ATRA | ATARA BIOTHERAPEUTICS INC | $83.86M | $11.94 | N/A | N/A | N/A | N/A | N/A | 24.54% | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $8.03B | $51.62 | $69.11 | 33.88% | Strong Buy | 9 | 4.69% | 106.41% | 16.23% | 12.18% | |||
| VCYT | VERACYTE INC | $2.50B | $31.87 | $42.00 | 31.79% | Strong Buy | 5 | 8.66% | 49.47% | 7.44% | 6.76% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.20B | $53.14 | $95.86 | 80.39% | Strong Buy | 7 | 7.44% | 18.16% | 21.19% | 17.12% | |||
| GMAB | GENMAB A | $17.96B | $27.99 | $41.00 | 46.48% | Strong Buy | 2 | 14.42% | 9.01% | 4.39% | 3.60% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.42B | $19.76 | N/A | N/A | N/A | N/A | 7.50% | 13.43% | 38.03% | 33.50% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $772.01M | $9.68 | $17.00 | 75.62% | Strong Buy | 3 | 15.50% | 0.11% | 38.51% | 27.01% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $100.82B | $393.21 | $488.35 | 24.20% | Buy | 17 | 7.30% | 10.67% | 33.80% | 24.15% | |||
| NVO | NOVO NORDISK A S | $248.34B | $55.62 | $67.00 | 20.46% | Buy | 2 | 5.56% | 5.05% | 97.75% | 34.07% | |||
| MNKD | MANNKIND CORP | $1.65B | $5.38 | $11.00 | 104.46% | Strong Buy | 4 | 10.83% | 8.37% | -211.83% | 28.32% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.